Search Results 11-20 of 13224 for COPD exacerbation

1. Mayo Clinic Q and A: Long-Term Antibiotic Use For Some With COPD

   Exacerbations are episodes when symptoms of COPD become worse than their usual day-to-day variation. Some exacerbations may be caused by a viral or bacterial ...

2. Chronic obstructive pulmonary disease: Risks, symptoms and prevention - Mayo Clinic News Network

   “COPD patients commonly experience what are known as exacerbations, which are periods where symptoms are worse than normal for several days,” says Shorter.

3. Emphysema - Symptoms and causes - Mayo Clinic

   Exacerbations may be caused by a respiratory infection, air pollution or other things that trigger inflammation. Whatever the cause, it's important to get ...

4. A Study Comparing The Efficacy, Safety And Tolerability Of Fixed Dose Combination (FDC) Of FF/UMEC/VI With The FDC Of FF/VI And UMEC/VI; Administered Once-daily Via A Dry Powder Inhaler (DPI) In Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   ... exacerbations or a documented history of >=1 severe COPD exacerbation (hospitalized) in the previous 12 months. Note: Percent predicted will be calculated ...

5. A Study Of Beta-Blockers For The Prevention Of Acute Worsening Of Chronic Obstructive Pulmonary Disease - Mayo Clinic

   The purpose of this study is to assess the effect of metoprolol for patients who have moderate to severe COPD, measuring the time to first acute exacerbation ( ...

6. Mindfulness to Mitigate the Effect of Anxiety-depression-fear in Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   Mindfulness to Mitigate the Effect of Anxiety-depression-fear in Chronic Obstructive Pulmonary Disease (COPD) ... exacerbations; all independent predictors of ...

7. Emphysema - Diagnosis and treatment - Mayo Clinic

   These medicines are useful if you often have exacerbations of emphysema. Combination inhalers. Some inhalers combine bronchodilators and inhaled steroids ...

8. A Study To Assess The Effectiveness, Safety And Tolerability Of Dupilumab In Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation - Mayo Clinic

   ... Chronic Obstructive Pulmonary Disease (COPD) as measured by - Annualized rate of acute moderate and severe COPD exacerbation (AECOPD). Participation ...

9. MyAirvo 3 (High Flow Nasal Therapy; HFNT) For COPD Patients In The Home - Mayo Clinic

   ... COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.

10. Study Of Tozorakimab To Treat Chronic Obstructive Pulmonary Disease (COPD) With A History Of Exacerbations - Mayo Clinic

    ... chronic obstructive pulmonary disease (COPD) exacerbation in former smokers. Participation eligibility. Participant eligibility includes age, gender, type ...